Christoph Spinner et al.: Starting or Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Clinical Practice: Pooled 12-month Results from the Global BICSTaR Study

Zurück zur Übersicht

25.-27.03.2021 / DÖAK 2021